AAAAAA
Results:
1-13
|
Results: 13
Authors:
KIM J
ZHI JG
SATOH H
KOSSTWARDY SG
PASSE SM
PATEL IH
PAZDUR R
Citation: J. Kim et al., PHARMACOKINETICS OF RECOMBINANT HUMAN INTERFERON-ALPHA-2A COMBINED WITH 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Anti-cancer drugs, 9(8), 1998, pp. 689-696
Authors:
XU ZX
RAKHIT A
PATEL IH
VANBRUMMELEN P
Citation: Zx. Xu et al., PK PD MODELING APPROACH TO SUPPORT CLINICAL DEVELOPMENT OF A LONG-ACTING INTERFERON (RO-25-3036) FOR THE TREATMENT OF CHRONIC HEPATITIS-C/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 101-101
Authors:
CHEN C
JENSEN BK
MISTRY G
WYSS R
ZULTAK M
PATEL IH
RAKHIT AK
Citation: C. Chen et al., NEGLIGIBLE SYSTEMIC ABSORPTION OF TOPICAL ISOTRETINOIN CREAM - IMPLICATIONS FOR TERATOGENICITY, Journal of clinical pharmacology, 37(4), 1997, pp. 279-284
Authors:
ZHI JG
MELIA AT
KOSSTWARDY SG
ARORA S
PATEL IH
Citation: Jg. Zhi et al., THE EFFECT OF ORLISTAT, AN INHIBITOR OF DIETARY-FAT ABSORPTION, ON THE PHARMACOKINETICS OF BETA-CAROTENE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(2), 1996, pp. 152-159
Authors:
NIEFORTH KA
NADEAU R
PATEL IH
MOULD D
Citation: Ka. Nieforth et al., USE OF AN INDIRECT PHARMACODYNAMIC STIMULATION MODEL OF MX PROTEIN INDUCTION TO COMPARE IN-VIVO ACTIVITY OF INTERFERON ALFA-2A AND A POLYETHYLENE GLYCOL-MODIFIED DERIVATIVE IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 59(6), 1996, pp. 636-646
Authors:
REIGNER BG
WILLIAMS PEO
PATEL IH
STEIMER JL
PECK C
VANBRUMMELEN P
Citation: Bg. Reigner et al., INTEGRATION OF PK PD HAS IMPROVED RECENT ROCHE DRUG DEVELOPMENT/, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 14-14
Authors:
CONNELLY MPE
FABIANO E
PATEL IH
KINYANJUI SM
MBERU EK
WATKINS WM
Citation: Mpe. Connelly et al., ANTIMALARIAL ACTIVITY IN CRUDE EXTRACTS OF MALAWIAN MEDICINAL-PLANTS, Annals of tropical medicine and parasitology, 90(6), 1996, pp. 597-602
Authors:
ZHI J
MELIA AT
KOSSTWARDY SG
MIN B
GUERCIOLINI R
FREUNDLICH NL
MILLA G
PATEL IH
Citation: J. Zhi et al., THE INFLUENCE OF ORLISTAT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF GLYBURIDE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 35(5), 1995, pp. 521-525
Authors:
ZHI JG
MELIA AT
EGGERS H
JOLY R
PATEL IH
Citation: Jg. Zhi et al., REVIEW OF LIMITED SYSTEMIC ABSORPTION OF ORLISTAT, A LIPASE INHIBITOR, IN HEALTHY-HUMAN VOLUNTEERS, Journal of clinical pharmacology, 35(11), 1995, pp. 1103-1108
Authors:
ZHI JG
RAKHIT A
PATEL IH
Citation: Jg. Zhi et al., EFFECTS OF DIETARY-FAT ON DRUG ABSORPTION - COMMENTARY, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 487-491
Authors:
MOULD DR
DEFEO TM
REELE S
MILLA G
LIMJUCO R
CREWS T
CHOMA N
PATEL IH
Citation: Dr. Mould et al., SIMULTANEOUS MODELING OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OFMIDAZOLAM AND DIAZEPAM, Clinical pharmacology and therapeutics, 58(1), 1995, pp. 35-43
Authors:
ZHI JG
MASSARELLA JW
MELIA AT
TELLER SB
SCHMITTMUSKUS J
CREWS T
OLDFIELD N
ERB RJ
LEESE PT
PATEL IH
Citation: Jg. Zhi et al., THE PHARMACOKINETIC-PHARMACODYNAMIC (DIGIT-SYMBOL-SUBSTITUTION-TEST) RELATIONSHIP OF FLUMAZENIL IN A MIDAZOLAM STEADY-STATE MODEL IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 56(5), 1994, pp. 530-536
Authors:
ZHI J
MELIA AT
GUERCIOLINI R
CHUNG J
KINBERG J
HAUPTMAN JB
PATEL IH
Citation: J. Zhi et al., RETROSPECTIVE POPULATION-BASED ANALYSIS OF THE DOSE-RESPONSE (FECAL FAT EXCRETION) RELATIONSHIP OF ORLISTAT IN NORMAL AND OBESE VOLUNTEERS, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 82-85
Risultati:
1-13
|